Market Cap 153.85B
Revenue (ttm) 24.57B
Net Income (ttm) 3.61B
EPS (ttm) N/A
PE Ratio 26.59
Forward PE 25.32
Profit Margin 14.71%
Debt to Equity Ratio 0.48
Volume 2,366,830
Avg Vol 5,038,322
Day's Range N/A - N/A
Shares Out 702.99M
Stochastic %K 91%
Beta 0.78
Analysts Strong Sell
Price Target $223.09

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cultu...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
onlythebestcompanies
onlythebestcompanies Aug. 24 at 5:17 PM
$DHR $280 soon.
0 · Reply
Quant_Builder
Quant_Builder Aug. 24 at 12:49 PM
$TMO $IYH $SPY $RSP $DHR quant-builder.ai Story is kinda the same. Buying solid dips over the next few weeks. The interest rate volatility might cause some sharp pullbacks, but we could get a ripping rally on any good news on rates. So, I'm going to nibble on each dip, try and get a little more invested, and trade the stocks in the models. For today at least I am dropping the Tech model I have been using, although I will want to get involved. I have my QB500 and Healthcare models pulled up. Ranked. There are actually a few tech names on here from the QB500 model so that's good enough. Healthcare still has high confidence and lots of picks, with TMO as the top pick, and it's on the verge of breaking out from a long-held resistance level. I own some, keeping some take profit takes tight in case it fails as well as a trailing stop. Good earnings, the Iran war is a known unknown, everything else we know. Inflation is sticky, the Fed may have to raise rates, the rates have been adjusting for that, jobs okay, and still an insane amount of infrastructure investment over the next 6-12 months. There really is no new economic news, just headline news and interest rate volatility. The first image is Today's Picks from those two models. Combined list, ranked by confidence. 41 deduplicated picks. TMO at the top then DHR, BIO, SYK. Tech is still on the page through QB500: SMCI, MU, ASTS. The second image is a history of these two models combined. Had you just opened Today's Picks every day and bought the top 20 at 1% per position at the opening price, used a −5% stop, and held through the target date, this is how it would perform. I don't do that exactly. I nibble, I skip names, I take profits etc. But, I do not just cherry pick one name and oversize it. Trade in batches with proper positions sizes.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 1:58 AM
$DHR Price: $218.85 (+1.36%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.53% RSI: 72.8 | Momentum: Moderate Volume: -6.4% vs avg Volatility: 1.90% Support: $189.85 | Resistance: $220.67 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
MoneyMacG
MoneyMacG Aug. 20 at 7:45 PM
0 · Reply
MoneyMacG
MoneyMacG Aug. 20 at 6:48 PM
$SPY $QQQ $RVTY $PCG $DHR interesting
0 · Reply
Quant_Builder
Quant_Builder Aug. 20 at 1:15 PM
$IYH $TMO $DHR $SPY $QQQ Raised Cash Yesterday on Healthcare Rally Yesterday the healthcare sector popped higher on Moderna with a successful drug trial. The healthcare stocks were steadily rising in the ranks of confidence in the week leading up to this rally. I owned TMO, AMGN, HUM, MRNA, WAT, BIO, SYK, DHR among a few others. I was relatively light on tech although I added some during the day yesterday, and I liquidated some older trades. I did a somewhat of a full circle this week. I started the end of last Thursday at 22% long, got up to ~70% Tuesday's close going into Wednesday, adding each day. Then after yesterday's exits got back down to ~21% I'm sticking to the list today. More tech has showed up, still a lot of healthcare. The model that kinda dropped off was the QB500 model in the number of high ranked picks. The market seems weak. I'm going to pick my spots on the open and stick to the models. I'll probably keep take profits pretty tight still. If the rates get under control and stabilize, I don't think we break down. QQQ is doing a lot of consolidation above 700 and below its old high, which is healthy. Using cash as a hedge instead of looking at anything short. The first image is Today's Picks from those same models. Combined list, ranked by confidence. The process is I choose a bunch of stocks from that list and batch trade them in groups. Set an entry and multiple ways to exit. Take profits in a step ladder for 0.5%-1% positions. So stock XYZ may get 3 lots of 1% with take profits at 2,5,7% as well as a Market on Close liquidation at the end of the model target (if enabled). This clears out trades that have neither hit the stop loss or the take profit for multiple days. The second image is a history of these models combined. Had you just opened Today's Picks every day and bought the top 20 at 1% per position at the opening price and held through the target date(no take profit), this is how it would perform. Build your models at quant-builder.ai Free Demo at quant-builder.ai/learn
0 · Reply
PaulineBoudreaux971
PaulineBoudreaux971 Aug. 20 at 7:30 AM
$DHR $ISRG $VRTX $BMY $PLD Danaher benefits from life-sciences and diagnostics demand, Intuitive Surgical benefits from robotic-surgery adoption, Vertex benefits from pharmaceutical demand and pipeline progress, Bristol Myers Squibb remains driven by its drug portfolio, and Prologis benefits from logistics and warehouse demand. I'm watching biopharma spending, procedure volumes, clinical milestones, drug sales, and occupancy.
0 · Reply
Do_The_Math
Do_The_Math Aug. 19 at 11:31 PM
$DHR $RGEN $TMO These named on $MRNA maybe good catalyst for entry although it’s separate from the idea. Anth tweet on biotech re: $TWST probably helping. Tight stop on adds below yday’s low on these names since every possible $MRNA fades and these do in sympathy
1 · Reply
notreload_ai
notreload_ai Aug. 19 at 2:12 PM
Wells Fargo & Stifel say Moderna-Merck Phase 3 cancer vaccine data could benefit $RGEN, $DHR, $TMO & $MRVI . https://notreload.xyz/xy/moderna-merck-cancer-vaccine-boosts-biotech-suppliers/
0 · Reply
FreeStockFinder
FreeStockFinder Aug. 19 at 2:05 PM
Large caps bullish after an hour $ACN $NOW $CRM $PGR $DHR
0 · Reply
Latest News on DHR
Danaher names Julie Sawyer Montgomery as CEO

2026-08-03T20:20:49.000Z - 21 days ago

Danaher names Julie Sawyer Montgomery as CEO


Danaher price target lowered to $230 from $270 at BofA

2026-07-22T12:45:26.000Z - 4 weeks ago

Danaher price target lowered to $230 from $270 at BofA


Danaher price target lowered to $236 from $240 at TD Cowen

2026-07-22T12:35:36.000Z - 4 weeks ago

Danaher price target lowered to $236 from $240 at TD Cowen


Danaher price target raised to $215 from $200 at RBC Capital

2026-07-22T11:21:07.000Z - 4 weeks ago

Danaher price target raised to $215 from $200 at RBC Capital


Danaher price target lowered to $220 from $260 at Stifel

2026-07-22T11:10:55.000Z - 4 weeks ago

Danaher price target lowered to $220 from $260 at Stifel


Danaher price target lowered to $200 from $235 at Guggenheim

2026-07-22T10:35:42.000Z - 4 weeks ago

Danaher price target lowered to $200 from $235 at Guggenheim


Danaher price target lowered to $195 from $212 at Wells Fargo

2026-07-22T10:31:09.000Z - 4 weeks ago

Danaher price target lowered to $195 from $212 at Wells Fargo


Don't Quit on Danaher Stock After Horrific Earnings Reaction

Jul 22, 2026, 5:06 AM EDT - 4 weeks ago

Don't Quit on Danaher Stock After Horrific Earnings Reaction


Danaher falls -14.3%

2026-07-21T16:05:28.000Z - 4 weeks ago

Danaher falls -14.3%


Danaher falls -12.4%

2026-07-21T14:06:03.000Z - 4 weeks ago

Danaher falls -12.4%


Danaher Earnings Call Transcript: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Danaher Earnings Call Transcript: Q2 2026


Danaher Quarterly report: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Danaher Quarterly report: Q2 2026


Danaher Earnings release: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Danaher Earnings release: Q2 2026


Danaher Slides: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Danaher Slides: Q2 2026


Danaher reports Q2 adjusted EPS $1.94, consensus $1.84

2026-07-21T10:07:16.000Z - 4 weeks ago

Danaher reports Q2 adjusted EPS $1.94, consensus $1.84


Danaher Reports Second Quarter 2026 Results

Jul 21, 2026, 6:00 AM EDT - 4 weeks ago

Danaher Reports Second Quarter 2026 Results


The Big 3: JPM, DHR, MRK

Jun 25, 2026, 1:00 PM EDT - 2 months ago

The Big 3: JPM, DHR, MRK

JPM MRK


Danaher Schedules Second Quarter 2026 Earnings Conference Call

Jun 22, 2026, 4:15 PM EDT - 2 months ago

Danaher Schedules Second Quarter 2026 Earnings Conference Call


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Danaher Completes Acquisition of Masimo Corporation

Jun 10, 2026, 8:55 AM EDT - 2 months ago

Danaher Completes Acquisition of Masimo Corporation


Sirius XM Holdings Set to Join S&P MidCap 400

Jun 8, 2026, 6:09 PM EDT - 2 months ago

Sirius XM Holdings Set to Join S&P MidCap 400

SPGI


Danaher Announces Quarterly Dividend

May 5, 2026, 4:30 PM EDT - 3 months ago

Danaher Announces Quarterly Dividend


Danaher Transcript: AGM 2026

May 5, 2026, 3:00 PM EDT - 3 months ago

Danaher Transcript: AGM 2026


Masimo Shareholders Approve Acquisition by Danaher

May 4, 2026, 9:00 AM EDT - 4 months ago

Masimo Shareholders Approve Acquisition by Danaher

MASI


Danaher Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Danaher Earnings Call Transcript: Q1 2026


Danaher Earnings release: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Danaher Earnings release: Q1 2026


Danaher Quarterly report: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Danaher Quarterly report: Q1 2026


Danaher Slides: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Danaher Slides: Q1 2026


Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Apr 21, 2026, 7:33 AM EDT - 4 months ago

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains


Danaher Reports First Quarter 2026 Results

Apr 21, 2026, 6:00 AM EDT - 4 months ago

Danaher Reports First Quarter 2026 Results


Danaher Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Danaher Proxy statement: Proxy filing


Danaher Proxy statement: Proxy filing

Mar 25, 2026, 8:00 AM EDT - 5 months ago

Danaher Proxy statement: Proxy filing


Danaher Schedules First Quarter 2026 Earnings Conference Call

Mar 20, 2026, 4:15 PM EDT - 5 months ago

Danaher Schedules First Quarter 2026 Earnings Conference Call


Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 1:50 PM EST - 6 months ago

Danaher Transcript: TD Cowen 46th Annual Health Care Conference


Danaher Slides: Corporate presentation

Feb 26, 2026, 7:00 AM EST - 6 months ago

Danaher Slides: Corporate presentation


Danaher to Present at TD Cowen Health Care Conference

Feb 24, 2026, 4:05 PM EST - 6 months ago

Danaher to Present at TD Cowen Health Care Conference


Danaher to buy Masimo for $9.9 billion

Feb 17, 2026, 8:04 AM EST - 6 months ago

Danaher to buy Masimo for $9.9 billion

MASI


Masimo to be Acquired by Danaher for $180.00 Per Share

Feb 17, 2026, 8:02 AM EST - 6 months ago

Masimo to be Acquired by Danaher for $180.00 Per Share

MASI


Danaher To Acquire Masimo Corporation

Feb 17, 2026, 8:00 AM EST - 6 months ago

Danaher To Acquire Masimo Corporation

MASI


Danaher Strikes $10 Billion Deal for Masimo

Feb 17, 2026, 6:09 AM EST - 6 months ago

Danaher Strikes $10 Billion Deal for Masimo

MASI


Danaher Earnings Call Transcript: Q4 2025

Jan 28, 2026, 8:00 AM EST - 7 months ago

Danaher Earnings Call Transcript: Q4 2025


Danaher Annual report: Q4 2025

Jan 28, 2026, 8:00 AM EST - 7 months ago

Danaher Annual report: Q4 2025


Danaher Earnings release: Q4 2025

Jan 28, 2026, 8:00 AM EST - 7 months ago

Danaher Earnings release: Q4 2025


Danaher Slides: Q4 2025

Jan 28, 2026, 8:00 AM EST - 7 months ago

Danaher Slides: Q4 2025


Danaher Reports Fourth Quarter and Full Year 2025 Results

Jan 28, 2026, 6:00 AM EST - 7 months ago

Danaher Reports Fourth Quarter and Full Year 2025 Results


Danaher Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 7 months ago

Danaher Slides: 44th Annual J.P. Morgan Healthcare Conference


Danaher CEO to Comment on Financial Performance

Jan 12, 2026, 9:00 AM EST - 8 months ago

Danaher CEO to Comment on Financial Performance


The Big 3: BA, DHR, DG

Jan 8, 2026, 1:05 PM EST - 8 months ago

The Big 3: BA, DHR, DG

BA DG


Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 8, 2026, 8:00 AM EST - 8 months ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It


Danaher to Present at J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:15 PM EST - 8 months ago

Danaher to Present at J.P. Morgan Healthcare Conference


Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 17, 2025, 7:30 AM EST - 8 months ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call


3 More Good Stocks to Invest In After Earnings

Nov 18, 2025, 4:29 PM EST - 9 months ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA


Danaher Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 6:00 AM EST - 9 months ago

Danaher Transcript: Jefferies London Healthcare Conference 2025


The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 10 months ago

The Big 3: TMO, DHR, VLO

TMO VLO


Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 10 months ago

Danaher to Present at Jefferies Global Healthcare Conference


Danaher Earnings Call Transcript: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 10 months ago

Danaher Earnings Call Transcript: Q3 2025


Danaher Quarterly report: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 10 months ago

Danaher Quarterly report: Q3 2025


Danaher Earnings release: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 10 months ago

Danaher Earnings release: Q3 2025


Danaher Slides: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 10 months ago

Danaher Slides: Q3 2025


Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 10 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum


onlythebestcompanies
onlythebestcompanies Aug. 24 at 5:17 PM
$DHR $280 soon.
0 · Reply
Quant_Builder
Quant_Builder Aug. 24 at 12:49 PM
$TMO $IYH $SPY $RSP $DHR quant-builder.ai Story is kinda the same. Buying solid dips over the next few weeks. The interest rate volatility might cause some sharp pullbacks, but we could get a ripping rally on any good news on rates. So, I'm going to nibble on each dip, try and get a little more invested, and trade the stocks in the models. For today at least I am dropping the Tech model I have been using, although I will want to get involved. I have my QB500 and Healthcare models pulled up. Ranked. There are actually a few tech names on here from the QB500 model so that's good enough. Healthcare still has high confidence and lots of picks, with TMO as the top pick, and it's on the verge of breaking out from a long-held resistance level. I own some, keeping some take profit takes tight in case it fails as well as a trailing stop. Good earnings, the Iran war is a known unknown, everything else we know. Inflation is sticky, the Fed may have to raise rates, the rates have been adjusting for that, jobs okay, and still an insane amount of infrastructure investment over the next 6-12 months. There really is no new economic news, just headline news and interest rate volatility. The first image is Today's Picks from those two models. Combined list, ranked by confidence. 41 deduplicated picks. TMO at the top then DHR, BIO, SYK. Tech is still on the page through QB500: SMCI, MU, ASTS. The second image is a history of these two models combined. Had you just opened Today's Picks every day and bought the top 20 at 1% per position at the opening price, used a −5% stop, and held through the target date, this is how it would perform. I don't do that exactly. I nibble, I skip names, I take profits etc. But, I do not just cherry pick one name and oversize it. Trade in batches with proper positions sizes.
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 1:58 AM
$DHR Price: $218.85 (+1.36%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.53% RSI: 72.8 | Momentum: Moderate Volume: -6.4% vs avg Volatility: 1.90% Support: $189.85 | Resistance: $220.67 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
MoneyMacG
MoneyMacG Aug. 20 at 7:45 PM
0 · Reply
MoneyMacG
MoneyMacG Aug. 20 at 6:48 PM
$SPY $QQQ $RVTY $PCG $DHR interesting
0 · Reply
Quant_Builder
Quant_Builder Aug. 20 at 1:15 PM
$IYH $TMO $DHR $SPY $QQQ Raised Cash Yesterday on Healthcare Rally Yesterday the healthcare sector popped higher on Moderna with a successful drug trial. The healthcare stocks were steadily rising in the ranks of confidence in the week leading up to this rally. I owned TMO, AMGN, HUM, MRNA, WAT, BIO, SYK, DHR among a few others. I was relatively light on tech although I added some during the day yesterday, and I liquidated some older trades. I did a somewhat of a full circle this week. I started the end of last Thursday at 22% long, got up to ~70% Tuesday's close going into Wednesday, adding each day. Then after yesterday's exits got back down to ~21% I'm sticking to the list today. More tech has showed up, still a lot of healthcare. The model that kinda dropped off was the QB500 model in the number of high ranked picks. The market seems weak. I'm going to pick my spots on the open and stick to the models. I'll probably keep take profits pretty tight still. If the rates get under control and stabilize, I don't think we break down. QQQ is doing a lot of consolidation above 700 and below its old high, which is healthy. Using cash as a hedge instead of looking at anything short. The first image is Today's Picks from those same models. Combined list, ranked by confidence. The process is I choose a bunch of stocks from that list and batch trade them in groups. Set an entry and multiple ways to exit. Take profits in a step ladder for 0.5%-1% positions. So stock XYZ may get 3 lots of 1% with take profits at 2,5,7% as well as a Market on Close liquidation at the end of the model target (if enabled). This clears out trades that have neither hit the stop loss or the take profit for multiple days. The second image is a history of these models combined. Had you just opened Today's Picks every day and bought the top 20 at 1% per position at the opening price and held through the target date(no take profit), this is how it would perform. Build your models at quant-builder.ai Free Demo at quant-builder.ai/learn
0 · Reply
PaulineBoudreaux971
PaulineBoudreaux971 Aug. 20 at 7:30 AM
$DHR $ISRG $VRTX $BMY $PLD Danaher benefits from life-sciences and diagnostics demand, Intuitive Surgical benefits from robotic-surgery adoption, Vertex benefits from pharmaceutical demand and pipeline progress, Bristol Myers Squibb remains driven by its drug portfolio, and Prologis benefits from logistics and warehouse demand. I'm watching biopharma spending, procedure volumes, clinical milestones, drug sales, and occupancy.
0 · Reply
Do_The_Math
Do_The_Math Aug. 19 at 11:31 PM
$DHR $RGEN $TMO These named on $MRNA maybe good catalyst for entry although it’s separate from the idea. Anth tweet on biotech re: $TWST probably helping. Tight stop on adds below yday’s low on these names since every possible $MRNA fades and these do in sympathy
1 · Reply
notreload_ai
notreload_ai Aug. 19 at 2:12 PM
Wells Fargo & Stifel say Moderna-Merck Phase 3 cancer vaccine data could benefit $RGEN, $DHR, $TMO & $MRVI . https://notreload.xyz/xy/moderna-merck-cancer-vaccine-boosts-biotech-suppliers/
0 · Reply
FreeStockFinder
FreeStockFinder Aug. 19 at 2:05 PM
Large caps bullish after an hour $ACN $NOW $CRM $PGR $DHR
0 · Reply
onlythebestcompanies
onlythebestcompanies Aug. 17 at 5:04 AM
$DHR $260 soon.
1 · Reply
BioTechHealthX
BioTechHealthX Aug. 15 at 5:34 PM
$DHR Danaher Corporation (NYSE: DHR) has exposure to bioprocessing, diagnostics and technologies supporting advanced drug manufacturing. Discover why DHR stock may offer investors a surprising way to play the GLP-1 and biotech growth story. https://biotechhealthx.com/biotech-news/is-danaher-dhr-a-smart-healthcare-stock-to-buy-right-now/
0 · Reply
Do_The_Math
Do_The_Math Aug. 15 at 12:02 AM
$RGEN $TMO etc charts look ripe + frontier AI labs are going to focus on biotech to win over the court of public opinion on AI. AI will speed up molecule discovery and drilling in on what molecules/targets to test but at the end of the day you still need to test, manufacture, etc. which requires real assets that these companies produce. Light position for now, just an idea but will take time to build conviction in it. Next market drawdown think worth while to see how these act. Already saw $DHR whiff on bio processing and fully retrace the move, that’s very valuable info in my opinion. Think some smarter people saw this idea months ago but think it’s very early if it comes to fruition.
1 · Reply
CheesyBurrito
CheesyBurrito Aug. 10 at 5:37 PM
$SGMO @pblegend66 Not only are both of the Danaher attorneys restructuring experts, more importantly Mr. Price is a partner and the vice chair of the firm. The other is their most senior associate for restructuring. It would be fairly unusual for two heavy hitters to attend simply to babysit maybe $100,000-ish in debt for an old centrifuge. Probably billing $10K-$15K or more for a day just to do that? I’d say no. This smells more like $DHR is a bidder.
0 · Reply
onlythebestcompanies
onlythebestcompanies Aug. 10 at 10:08 AM
$DHR $300 soon.
0 · Reply
OliviaStonge777
OliviaStonge777 Aug. 9 at 2:34 PM
$DHR $UL $PLD $APP $LMT Danaher remains a life sciences leader, Unilever benefits from global consumer brands, Prologis dominates logistics real estate, AppLovin expands AI advertising, and Lockheed Martin leads defense technology.
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 9 at 2:47 AM
$GILD $ABT $DHR $LLY $MRK Analysts see meaningful upside in several top healthcare stocks for 2026, with one biotech leader offering nearly 30% implied upside based on the analyst target and supplied market price. https://biotechhealthx.com/biotech-news/top-5-healthcare-stocks-to-buy-with-1000-in-2026/
0 · Reply
KathleenFinch1000
KathleenFinch1000 Aug. 8 at 4:42 PM
$BBVA $UBER $PFE $WDC $DHR BBVA benefits from diversified banking exposure, Uber continues gaining share in mobility and delivery, Pfizer advances its pharmaceutical pipeline, Western Digital benefits from AI-driven storage demand, and Danaher remains a leader in life-science tools. I'm watching margins, demand, and pipeline progress.
0 · Reply
11thestate
11thestate Aug. 7 at 2:17 PM
FAQ on everything you need to know about the $172.5M Danaher ($DHR) Settlement payout Q: What happened? A: Danaher was accused of overstating demand and growth expectations in its bioprocessing business as COVID-related demand began to weaken. The company repeatedly cut its forecasts, and investors alleged that Danaher had downplayed inventory buildup and weakening orders. Q: Am I actually eligible? A: If you bought $DHR shares between 2022 and 2023, you’re likely eligible. You don’t need to still hold the stock to claim; past losses count Q: When is the deadline? A: Eligible investors have until September 20, 2026 to submit a claim. Q: When do payouts happen? A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration. Check if you're eligible and submit your claims: https://11th.com/cases/danaher-investor-settlement
0 · Reply
Estimize
Estimize Aug. 6 at 11:03 PM
Wall St is expecting 1.92 EPS for $DHR Q3 [Reporting 10/27 BMO] http://www.estimize.com/intro/dhr?chart=historical&metric_name=eps&utm_cont
0 · Reply
Popo_Jijo
Popo_Jijo Aug. 3 at 10:04 PM
$DHR thank you board
3 · Reply
onlythebestcompanies
onlythebestcompanies Aug. 3 at 3:43 PM
$DHR $300 soon.
0 · Reply